Skip to content

HNGE HNGE Additional Paid-In Capital

Additional Paid-In Capital at other companies

Globus Medical logo
Globus MedicalGMED
$3.21B+5.0%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$656.44M-11.5%
Solventum logo
SolventumSOLV
$3.9B+3.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$10.2B+1.1%
Medtronic logo
MedtronicMDT
$20.93B+0.4%

Other financials

Income statement

See full
Revenue$182.3M+47.2%
Gross profit$154.2M+53.9%
Operating income$32.1M+144%
Net income$35.1M+105%
EPS (diluted)$0.41-68.7%

Balance sheet

See full
Cash & equivalents$188.1M-35.2%
Total debt$7.0M
Total equity$111.7M+136%
Total assets$728.8M

Cash flow

See full
Operating cash flow$43.1M+775%
CapEx$83.0K+62.7%
Free cash flow$43.0M+782%

Valuation

See full
Market cap$5.37B
Enterprise value$5.19B
P/S8.3×

Profitability

See full
Gross margin80.8%+1.5pp
Operating margin-85.8%
Net margin-83.9%
FCF margin32.3%

Returns & leverage

See full
Return on equity551.8%
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HNGE's additional paid-in capital?
HNGE (HNGE) reported additional paid-in capital of $1.13B in Q1 2026.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.